Moderna Stock Crashes 17% After Covid Vaccine Maker Slashes …

Moderna Stock Crashes 17% After Covid Vaccine Maker Slashes …

3 weeks from now

Jan 13, 2025  · Moderna also cut its 2025 outlook and now projects just $1.5 billion to $2.5 billion, well below its prior view for $2.5 billion to $3.5 billion. Moderna stock crashed 16.8%, closing …

investors.com

Moderna Stock: Covid Vaccine Maker Smashes Sales Views, But …

3 weeks from now

Aug 1, 2024  · Moderna owns about 40% of the Covid vaccine market, Needham analyst Joseph Stringer said in a report. He estimates Pfizer and BioNTech hold the other 60%. "The …

investors.com

Moderna Cuts 2025 Sales Forecast By $1 Bln On Weak Vaccine …

3 weeks from now

Jan 13, 2025  · Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 …

reuters.com

Why Moderna Stock Just Crashed 21% - The Motley Fool

3 weeks from now

Jan 13, 2025  · Moderna's (MRNA 0.58%) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET …

fool.com

Moderna Cuts 2025 Sales Forecast By $1 Billion On Weak Vaccine …

3 weeks from now

Jan 13, 2025  · (Reuters) -Moderna (MRNA) cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for …

yahoo.com

Moderna Shares Slide After Sales Guidance Slashed - Financial Times

3 weeks from now

Jan 13, 2025  · Moderna stock fell as low as $31.94, more than 90 per cent down from its peak in September 2021, when its Covid-19 shots were rolling out during the pandemic. The shares …

ft.com

Moderna: Fair Value Cut Following Lower 2025 Sales ... - Morningstar

3 weeks from now

Jan 14, 2025  · On Jan.13, Moderna cut its 2025 sales guidance to $1.5 billion-$2.5 billion, down from prior guidance of $2.5 billion-$3.5 billion, partly due to waning covid vaccine demand and …

morningstar.com

Moderna Cuts Sales Forecast On Weaker Vaccine Demand

3 weeks from now

Jan 13, 2025  · Moderna cut its 2025 forecast by $1 billion Monday, citing weak demand for its newest vaccine as well as slow sales for its COVID-19 vaccine. The company now expects …

yahoo.com

Why Moderna Stock Just Crashed 21% - Yahoo Finance

3 weeks from now

Jan 13, 2025  · Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET …

yahoo.com

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

3 weeks from now

Mock pointed to four factors that could weigh on sales, including increased competition in the Covid market. He said Moderna's share of the U.S. retail market for Covid shots fell to 40% at …

msn.com

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

3 weeks from now

Jan 14, 2025  · It now forecasts total revenues in the range of $1.5 to $2.5 billion, mainly from product sales of its COVID-19 and RSV vaccines. Management expects to generate the …

nasdaq.com

Watch These Moderna Price Levels As Stock Plummets After

3 weeks from now

Jan 14, 2025  · Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. Watch these …

investopedia.com

Moderna Reports Surprise Profit On Higher-than-expected COVID …

3 weeks from now

Nov 7, 2024  · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The …

reuters.com

Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are …

3 weeks from now

Moderna stock falls after Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed price target to $51 from $99 Wednesday.

barrons.com

What Led To Moderna’s 20% Stock Drop? Here’s The Full Story

3 weeks from now

Jan 13, 2025  · The company anticipates three approvals in 2025 alone and is focusing on its messenger RNA platform technology, which underpins both its Covid and RSV vaccines. As of …

dataconomy.com

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

3 weeks from now

Oct 16, 2024  · In the past month, the stock has underperformed the industry’s 2.3% fall, as seen in the chart below. It has also underperformed the sector and the S&P 500. Shares of …

nasdaq.com

Moderna Crashes After Slashing Its R&D Budget By $1.1 Billion

3 weeks from now

Sep 16, 2024  · Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget by $1.1 billion and issued light 2025 sales guidance. The company says its investment …

investors.com

Why Moderna Stock Jumped Over 20% This Week - Nasdaq

3 weeks from now

6 days ago  · The maker of vaccines, including the mRNA vaccine for COVID-19, is amid a 90% stock price downturn. In fact, the share price is now only right around the same level as it was …

nasdaq.com

Moderna Stock Surges 14% After Covid Vaccine-Maker Surprises …

3 weeks from now

Feb 22, 2024  · Moderna stock analysts model $321 million in sales of the company's vaccine this year. Mock notes Moderna's shot uses a pre-filled syringe, which could help it gain share from …

investors.com